Liver Disease Clinical Trials

Showing 561-580 of 690 trials

Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients

NCT01999101

The primary aim of the study is to evaluate the safety and tolerability of Px-104 in NAFLD patients and to assess the influence of Px-104 on hepatic fat.

Non Alcoholic Fatty Liver Disease

Phenex Pharmaceuticals AG12 participantsStarted Oct 2013

Vienna, Austria

COMPLETEDPHASE2

Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis

NCT01591200

This study will evaluate the safety and efficacy of mesenchymal stem cells in patients with cirrhosis of liver. Stem cells will be injected into the hepatic artery. Improvement in various parameters will be observed over 2 years.

Alcoholic Liver Cirrhosis

Stempeutics Research Pvt Ltd40 participantsStarted Jun 2012

Hyderabad, Andhra Pradesh, India • Hyderabad, Andhra Pradesh, India • Bangalore, Karnataka, India +7 more locations

UNKNOWNPHASE4

Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response

NCT01530711

Observe the effect of terlipressin on renal function in patients with SHR type I adjusting the dose based on hemodynamic response.

CirrhosisHepatorenal Syndrome Type I

Pere Gines40 participantsStarted Apr 2012

Barcelona, Barcelona, Spain • Barcelona, Barcelona, Spain • Barcelona, Barcelona, Spain +3 more locations

Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients

Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis

Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response

Related Searches

Renal Function Determination in Patients With Liver Cirrhosis

Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With Cirrhosis

Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic Risk

Evaluation of EV1000™/volumeView™ for Cardiac Output Monitoring in Liver Transplantation

Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates

Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis

REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)

The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding

Mesenchymal Stem Cells Treat Liver Cirrhosis

Evaluating Ultrasound, Elastometry, Minilaparoscopy and Histology for the Diagnosis of Compensated Liver Cirrhosis.

Improvement of Transient Elastography Applicability and Diagnostic Accuracy to Identify Significant Fibrosis by Experienced Operators Using the M and XL Probe.

DHA and Vitamin D in Children With Biopsy-proven NAFLD

Impact of Ketogenic Diet on Lipoproteins in Refractory Epilepsy

Monitoring of Encephalopathy in Cirrhotic Patients Admitted in Intensive Care

Fatty Acids Lipidome and Oxidative Stress in Liver Transplantation

Hepatic Venous Pressure Gradient and Platelet Activation in Chronic Liver Disease